Xue Chen

1.3k total citations · 3 hit papers
26 papers, 750 citations indexed

About

Xue Chen is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xue Chen has authored 26 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xue Chen's work include Ferroptosis and cancer prognosis (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Xue Chen is often cited by papers focused on Ferroptosis and cancer prognosis (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Xue Chen collaborates with scholars based in China, United States and Hong Kong. Xue Chen's co-authors include Nayiyuan Wu, Li He, Yu Zhao, Ting Hong, Guang Lei, Yilei Zhang, Jing Wang, Xiaoye Zhang, Juan Lu and Qingfei Chu and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and FEBS Letters.

In The Last Decade

Xue Chen

23 papers receiving 742 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer

2021 252 citations Ting Hong, Guang Lei et al. Redox Biology profile →
Current understanding of the intratumoral microbiome in various tumors

2023 90 citations Xue Chen, Qingfei Chu et al. profile →
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances

2025 39 citations Xue Chen, Qingfei Chu et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xue Chen China	12	377	284	259	199	76	26	750
Aiqin Gu China	18	489 1.3×	254 0.9×	262 1.0×	314 1.6×	64 0.8×	65	1.0k
Li Yan China	18	393 1.0×	336 1.2×	178 0.7×	206 1.0×	81 1.1×	54	872
Haijun Yu China	17	335 0.9×	272 1.0×	109 0.4×	126 0.6×	87 1.1×	54	777
Franco Conforti United Kingdom	12	430 1.1×	354 1.2×	188 0.7×	116 0.6×	44 0.6×	22	831
Julie Giraud France	15	496 1.3×	346 1.2×	139 0.5×	198 1.0×	118 1.6×	25	941
Dan Zang China	18	486 1.3×	237 0.8×	115 0.4×	166 0.8×	68 0.9×	39	804
Tianyun Qiao China	10	543 1.4×	261 0.9×	132 0.5×	416 2.1×	148 1.9×	17	938
Yu Bai China	16	451 1.2×	228 0.8×	159 0.6×	253 1.3×	177 2.3×	49	848
Yulin Sun China	20	649 1.7×	231 0.8×	163 0.6×	375 1.9×	84 1.1×	56	1.0k
Taohua Yue China	15	330 0.9×	144 0.5×	143 0.6×	174 0.9×	56 0.7×	24	607

Countries citing papers authored by Xue Chen

Since Specialization

Citations

This map shows the geographic impact of Xue Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Chen more than expected).

Fields of papers citing papers by Xue Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Chen. The network helps show where Xue Chen may publish in the future.

Co-authorship network of co-authors of Xue Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Chen. A scholar is included among the top collaborators of Xue Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Chen. Xue Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xinshu, Xue Chen, & Hua Guo. (2025). Plasminogen activator inhibitor 1 is a novel predictor in human serum/follicular fluid for diminished ovarian reserve. BMC Women s Health. 25(1). 210–210. 1 indexed citations

Chen, Xue, Qingfei Chu, Qingmiao Shi, et al.. (2025). Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances. Signal Transduction and Targeted Therapy. 10(1). 106–106. 39 indexed citations breakdown →

Chen, Xue, et al.. (2025). Membraneless organelles-based integrative analysis constructs an immune-related prognostic signature and identifies NRG1 as a novel methylation biomarker in colorectal cancer. Frontiers in Immunology. 16. 1678096–1678096.

Chang, Xiao, et al.. (2024). PAI-1 siRNA-loaded biomimetic nanoparticles for ameliorating diminished ovarian reserve and inhibiting ovarian fibrosis. European Journal of Pharmacology. 983. 176948–176948. 1 indexed citations

Shi, Qingmiao, et al.. (2024). Berberine Protects against Hepatocellular Carcinoma Progression by Regulating Intrahepatic T Cell Heterogeneity. Advanced Science. 11(39). e2405182–e2405182. 4 indexed citations

Chen, Xue, et al.. (2023). Analysis of metabolic syndrome and cognitive functional analysis in schizophrenic patients based on psychological intervention. Preventive Medicine. 173. 107586–107586. 2 indexed citations

Chen, Yongchang, Lu Liu, Longzheng Xia, et al.. (2022). TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation. Journal of Experimental & Clinical Cancer Research. 41(1). 44–44. 58 indexed citations

Zhang, Zeyu, Xue Chen, Liu Li, et al.. (2022). Stress-, Anxiety-, and Cellphone use-induced Sleep Deficits and Psychological Conditions during the Pandemic and a Potential Remedy: a Randomized, Parallel, Blinded, Placebo-controlled Study. International Journal of Biomedical Science. 18(3). 41–53. 1 indexed citations

Jing, Ying, Xue Chen, Kunyan Li, et al.. (2022). Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy. Journal for ImmunoTherapy of Cancer. 10(1). e003779–e003779. 69 indexed citations

10.

Jing, Ying, Yongchang Zhang, Jing Wang, et al.. (2021). Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy. JNCI Journal of the National Cancer Institute. 113(10). 1396–1404. 75 indexed citations

11.

Chen, Xue, Qiao Li, Wang Yan, et al.. (2021). Bacilluspromotes invasiveness of exoticFlaveria bidentisby increasing its nitrogen and phosphorus uptake. Journal of Plant Ecology. 15(3). 596–609. 13 indexed citations

12.

Hong, Ting, Guang Lei, Xue Chen, et al.. (2021). PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer. Redox Biology. 42. 101928–101928. 252 indexed citations breakdown →

13.

Heng, Jianfu, Xue Chen, Jingjing Bao, et al.. (2021). Evaluation of the pharmacokinetic effects of itraconazole on alflutinib (AST2818): an open-label, single-center, single-sequence, two-period randomized study in healthy volunteers. European Journal of Pharmaceutical Sciences. 162. 105815–105815. 5 indexed citations

14.

Chen, Xue, Jie Fang, Rony Mia, et al.. (2021). A smart chitosan nonwoven fabric coated with coumarin-based fluorophore for selective detection and efficient adsorption of mercury (II) in water. Sensors and Actuators B Chemical. 342. 130064–130064. 30 indexed citations

15.

Chen, Xue, Jiao Zhao, Jianfu Heng, et al.. (2021). Effect of fluconazole on the pharmacokinetics of fuzuloparib: an open-label, crossover study in Chinese healthy male volunteers. Cancer Chemotherapy and Pharmacology. 89(1). 141–148. 8 indexed citations

16.

Chen, Yong, Yun Jiang, Jingjing Qu, et al.. (2020). Pharmacokinetic and bioequivalence study of new S-1 capsule in Chinese cancer patients. European Journal of Pharmaceutical Sciences. 151. 105384–105384. 2 indexed citations

17.

Xie, Li, et al.. (2020). Modified Maxillary-Swing Approach for Resection of Primary Malignancies in the Pterygopalatine Fossa. Frontiers in Oncology. 10. 530381–530381. 1 indexed citations

18.

Chen, Xue, et al.. (2016). A preliminary study of internet-based cognitive behavior therapy intervent medical university students' social anxiety. Zhonghua xingwei yixue yu naokexue zazhi. 21(2). 174–176. 1 indexed citations

19.

Li, Lili, Wei Li, Lanbo Xiao, et al.. (2012). Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53. Cell Cycle. 11(12). 2327–2336. 48 indexed citations

20.

Li, Lili, Shanghui Zhou, Xue Chen, et al.. (2008). The activation of p53 mediated by Epstein‐Barr virus latent membrane protein 1 in SV40 large T‐antigen transformed cells. FEBS Letters. 582(5). 755–762. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact